LUMICKS Unveils Avidion: A Breakthrough in Cell Therapy Development Discover how LUMICKS's Avidion platform transforms cell therapy by providing crucial insights into immune drug-tumor interactions, enhancing preclinical success.

LUMICKS Unveils Avidion: A Breakthrough in Cell Therapy Development #None #Utrecht #Cell_Therapy #Avidion #LUMICKS

People waiting at the booth with the Avidion at a booth at AACR

Come by and say hi to the newest central member of our booth setup:

#Avidion - The next generation Cell Avidity platform!

📍 Join us at AACR booth #633.

The LUMICKS team is ready to meet you at the American Association for Cancer Research (AACR) Annual Meeting.

Avidion AACR

🚀 Something BIG is coming to #AACR2025! 🚀

Visit booth #633 from April 25-30 to explore what’s possible with next generation Cell Avidity! Chat with our scientists about the breakthrough technology!

More news later this week.

#CellAvidity #Avidion #Immunotherapy #CancerResearch